Gene Predictis is a Swiss company dedicated to predictive medicine in the field of genetics. The goal is promotion of predictive diagnosis based on the analysis of genetic variants, paving the way to a highly personalised medical advice.
The company was founded in 2005 and the laboratory facilities were opened in September 2007. The panels of the services we offer are all based on DNA/RNA technologies.
- Currently the company focuses on genetic diagnosis for personalised drug treatment and prevention of certain diseases such as cardio-vascular illnesses, high blood pressure, coagulation disorders or gluten intolerance.
- In parallel, Gene Predictis proposes its platform and savoir faire for genetic biomarker discovery. Gene Predictis is also active in the fields of Molecular Oncology and Molecular Microbiology.
Gene Predictis is based in Granges-Paccot (Fribourg, Switzerland) and aims to become the Swiss reference company in pharmacogenetics.
